.......and the Chair and the Directors keep sucking out those lovely fees and yet have the nerve to outsource the Strategic Review.Why are you shareholders paying these clowns?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025